Innovation Pharmaceuticals Inc (IPIX)

[MackG]

I'm excited to have the incredible opportunity as an IPIX shareholder to be able to purchase additional ownership interest in BeaMed for a penny or two per share and watch this dynamic laser technology unfold this year. Innovation Pharmaceuticals (IPIX) informed us via press releases that following the closing under the Purchase Agreement in June, 2022, IPIX owns approximately 35.7% of BT BeaMedical Technologies, LTD (formerly known as Squalus Medical Ltd.) outstanding equity securities, and approximately 41.6% of BeaMed's equity securities on a fully diluted basis. IPIX investors and potential new investors can read about BeaMed's rapid advance of its new image guided surgical laser platform for treating previously inoperable cases of epilepsy and for enabling new treatment options for cancer cases in multiple specialties. You can review additional information on BeaMed's website.